-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Downgrades Centessa Pharmaceuticals to Neutral

Benzinga·04/02/2026 13:47:02
Listen to the news
Guggenheim analyst Debjit Chattopadhyay downgrades Centessa Pharmaceuticals (NASDAQ:CNTA) from Buy to Neutral.